Avid Bioservices Inc (CDMO)

[biopharm]

Why has Ronin Hedge Group not filed yet with SEC to amend their filings and remove ANY and ALL statements for wanting to shut down Peregrine R&D re: PS Targeting...

Hell, NO mention of their experts and have they not just seen the upfront abstract info for this weekend at SITC 2017 where the Bavituximab arm of patients that went on with FDA SOC have not met MOS yet!!!! Vs the Docetaxel arm have reached MOS

What do they not understand ? PS Targeting trying to be handcuffed by a Ronin Hedge Group BOD where it then can be transferred like Medarex for Breadcrumbs ??? No way.....let's go Ronin ....speak and file with SEC that R&D is here to stay ...with NCCN, MSK and Dr Jedd Wolchok and ALL other undisclosed collaborations

Biomarkers being minted as we speak and could be the goldmine all BPs require for fast FDA approvals and may not even need large clinical trials the way we knew it....

The Enlightenment Age of Disease.....is here now and others will require PS Targeting as well. Beth Seidenberg has had some interesting words lately, that Big Pharma is the last segment for paradigm shifts that have not shaken up the industry YET

Speaking of Tesaro, Tesaro, Incyte and Juno sponsoring this Jan 2018 conference....that Peregrine collaborator MSKs Dr Jedd Wolchok (scientific organizer at event) will be presenting .....(wonder which combos he will discuss and this is exactly why Ronin group must not halt PS Targeting with Dr Wolchok or MSK or NCCN or others....

ASK Stephen White / Ronin group to not halt PS Targeting activity because it is possible that any unfinished data that is maturing may not reach publication or symposiums such as below in 5 months. Why the hell does Ronin group not file with SEC to legally back up what Peregrine investors want?? Any collaborations with Dr Jedd Wolchok ...MSK .NCCN etc must stay active or does Ronin group have an agenda to cancel these collaborations ???
..

.